北京重组人VEGFR1(FLT1)(血管内皮生长因子受体1)品Pai

特别声明：本产品及我公司所售其他产品均为科研类试剂产品，严禁用于药物、YL及其他非科研用途。

北京重组人VEGFR1(FLT1)(血管内皮生长因子受体1)品Pai是高品质的分子生物学试剂产品，由北京百奥莱博供应，用于科研实验，本产品质量好，且极具价格优势，深为用户称道，了解更多重组人VEGFR1(FLT1)(血管内皮生长因子受体1)等分子生物学试剂产品请联系我司咨询订购。

名称：重组人VEGFR1(FLT1)(血管内皮生长因子受体1)
产地：国产|进口
编号：JN1380
品Pai：百奥莱博
英文名：Recombinant Human Vascular Endothelial Growth Factor Receptor 1
规格：10μg|50μg|500μg|1mg
本品由我们的哺乳动物细胞表达系统制备而成，目的基因编码的Ser27-Asn756在C端带有Fc标签。

VEGFR1/FLT1质量控制：＞95%(还原性SDS-PAGE)

VEGFR1/FLT1制剂：冻干品

VEGFR1/FLT1保存：
冻干蛋白置于-20℃以下可长期保存，室温条件下可稳定保存3周。
复溶蛋白溶液可在4～7℃保存2～7天，可分装后置于-20℃保存三个月。

VEGFR1/FLT1复溶：
打开试剂管前请先离心。
复溶浓度推荐大于100 μg/ml。
冻干蛋白请溶于ddH2O。
复溶后，请根据用量分装冻存，避免反复冻融。

关于VEGFR1/FLT1：
Human Vascular endothelial growth factor receptor 1(VEGFR-1, FLT-1) is a member of the the class III subfamily of receptor tyrosine kinases (RTKs) and Tyr protein kinase family and CSF-1/PDGF receptor subfamily. VEGFR-1 is widely expressed in human tissues including normal lung, placenta, liver, kidney, heart and brain tissues. It is specifically expressed in most of the vascular endothelial cellsand peripheral blood monocytes. VEGFR-1 contains seven Ig-like C2-type domains and one protein kinase domain. VEGFR-1is an essential receptor tyrosine kinase and plays an important role in theregulation of VEGF family-mediated vasculogenesis, angiogenesis, and lymphangiogenesis. It is also mediators of neurotrophic activity and regulators of hematopoietic development.VEGFR-1 is a receptor for VEGF, VEGFB and PGF. It has a tyrosine-protein kinase activity. Tyrosine-protein kinase that acts as a cell-surface receptor for VEGFA, VEGFB and PGF.It may play an essential role as a negative regulator of embryonic angiogenesis by inhibiting excessive proliferation of endothelial cells and promote endothelial cell proliferation, survival and angiogenesis in adulthood. Its function in promoting cell proliferation seems to be cell-type specific. VEGFR-1 can also promote PGF-mediated proliferation of endothelial cells, proliferation of some types of cancer cells, but does not promote proliferation of normal fibroblasts (in vitro).
关键词：重组人FLT1,重组人血管内皮生长因子受体1,重组人VEGFR1,重组人VEGFR1蛋白,JN1380


除北京重组人VEGFR1(FLT1)(血管内皮生长因子受体1)品Pai外，我公司正在打折促销以下产品：

编号	名称
JN1576	重组小鼠B7-2(CD86)
JN2030	重组人磷酸丙糖异构酶(TIM)
JN0151	亮*酸脱*酶
JN1732	重组人Carboxypeptidase A1(羧肽酶A1)(CPA1)
JN1995	重组人脂肪酸结合蛋白6(FABP6)
JN1935	重组人瓣状内切核酸酶1(FEN-1)
JN1366	重组小鼠胸腺基质淋巴细胞生成素(TSLP)
JN1342	重组人NRG-1β(神经调节蛋白1β)(神经调节素-1β)
JN0331	重组小鼠趋化因子CCL2(MCP-1)
JN0584	重组人MICA
JN1702	重组人Serpin A3(丝*酸蛋白酶YZ剂A3)
JN1435	重组小鼠外异蛋白A受体(Edar)
JN0985	重组人细胞色素C(CYCS)
JN0030	2×Taq MasterMix
JN0723	重组人ADPRH(ADP核糖精*酸水解酶)
JN2000	重组人γ谷*酰*环化转移酶(GGACT)
JN1343	重组人过氧化物还原蛋白4(Peroxiredoxin 4)
JN0245	重组人VEGF-A(血管内皮生长因子A)(带His标签)
JN1268	重组人MMP-9(基质金属蛋白酶-9)
JN0538	重组人NCR3(天然细胞毒性触发受体3)
JN1300	重组人KEL(Kelch样蛋白41)
JN1761	重组人Cystatin C(胱抑素C)
JN1519	重组小鼠IL-22(C端带mFc标签)
JN0223	重组人NT3(神经营养素3)(含前导肽)
JN0533	重组人迁移率族蛋白B1(HMGB1)
JN1711	重组人激肽释放酶(Kallikrein 4)(KLK4)
JN0160	TEV蛋白酶
JN0810	重组人PRAP1(酸性富脯*酸蛋白1)
JN1832	重组人CD33(Siglec-3)
JN0930	重组人BAX蛋白(Bcl-2相关X蛋白)
JN1398	重组小鼠IL-36b(IL-1F8)
JN1710	重组人激肽释放酶(Kallikrein 11)(KLK11)
JN0537	重组人光蛋白聚糖(Lumican)
JN1395	重组人载脂蛋白A-I(ApoA1)